Instruction for use: Fazin

Trade name of the drug – Fazin

ATX code R01AA05 Oxymetazoline

Pharmacotherapeutic group:

Alpha-adrenoceptor agonists

decongestant

The nosological classification (ICD-10)

H66 Suppurative and unspecified otitis media

Bacterial ear infections, Inflammation of the middle ear, Infections of the upper respiratory tract, Infectious-inflammatory diseases of ENT organs, Infectious-inflammatory diseases of upper respiratory tract, Infectious-inflammatory diseases of the ear, Infectious diseases of ENT organs with marked pain syndrome, ear Infection, Otitis media infection, Persistent inflammation of the middle ear in children, Ear pain of otitis

J30 Vasomotor and allergic rhinitis

Allergic rinopatiya, Allergic rhinosinusopathy, Allergic respiratory diseases, Allergic rhinitis, nasal allergy, Seasonal Allergic Rhinitis, Vasomotor rhinitis, Long-allergic rhinitis, Perennial allergic rhinitis, Perennial allergic rhinitis, Year-round or seasonal allergic rhinitis, Year-round allergic rhinitis nature, Rhinitis allergic vasomotor, Exacerbation of pollen allergy in the form of Syndrome rinokonyunktivalnogo, Acute allergic rhinitis, Edema of the nasal mucosa, Edema of the nasal mucosa, Swelling of the mucosa of the nasal cavity, Swelling of the nasal mucosa, Swelling of the nasal mucosa, pollen disease, Permanent allergic rhinitis, rhinoconjunctivitis, rhinosinusitis,rhinosinusopathy, Seasonal allergic rhinitis, Seasonal Allergic Rhinitis, Haymarket rhinitis, Chronic allergic rhinitis, Allergic respiratory diseases

J31 Chronic rhinitis, nasopharyngitis and pharyngitis

Allergic rhinosinusopathy, Inflammation of the nasal mucosa, Infectious-inflammatory diseases of upper respiratory tract, Catarrh nasopharyngeal area, Year-round rhinitis, Özen, Sore throat or nose hyperplastic, Rhinitis, Faringoezofagit, Chronic bacterial rhinitis

J32 Chronic sinusitis

Allergic rhinosinusopathy, purulent sinusitis, Catarrh nasopharyngeal area, Catarrh of the sinuses, Exacerbation of sinusitis, chronic Sinusitis

Composition

1 ml of solution contains 0.5 mg oxymetazoline hydrochloride; in vials-droppers of 30 ml.

Pharmacological Properties of FazinPharmachologic effect
vasoconstrictor, decongestant

pharmacodynamics

Narrowing of arterioles of the nasal mucosa, which leads to a reduction in edema, hyperemia and exudation.

Indications for Fazin
Acute rhinitis, sinusitis, evstahiit, otitis media.

Contraindications for Fazin

Hypersensitivity, dry rhinitis, chronic heart failure, hyperthyroidism, diabetes mellitus, pregnancy, children's age (up to 1 year).

Side effect of Fazin

Burning and dryness of the nasal passages, sneezing, dry mouth and throat, nausea, dizziness, irritability, insomnia, palpitations, hypertension; atrophy of the mucosa (with prolonged use).

Dosage and Administration

Intranasal, adults and children over 6 years - 2-3 drops in each nostril once every 10-12 hours.

Precautionary measures

It is recommended to use no more than 3 days. If during this period no improvement is observed, it is necessary to consult a doctor. Children from 1 year to 6 years are used only after consulting a doctor.

Storage conditions of Fazin

At a temperature of 2-30 ° C.

Keep out of the reach of children.
Shelf life of Fazin

2 years.

Do not use beyond the expiration date printed on the package.